These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 19131784

  • 1. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
    Peritz DC, Duncan C, Kurek K, Perez-Atayde AR, Lehmann LE.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
    [Abstract] [Full Text] [Related]

  • 2. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature.
    David DS, Tegtmeier BR, O'Donnell MR, Paz IB, McCarty TM.
    Am J Gastroenterol; 1998 May; 93(5):810-3. PubMed ID: 9625133
    [Abstract] [Full Text] [Related]

  • 3. Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
    Doki N, Miyawaki S, Tanaka M, Kudo D, Wake A, Oshima K, Fujita H, Uehara T, Hyo R, Mori T, Takahashi S, Okamoto S, Sakamaki H, Kanto Study Group for Cell Therapy.
    Transpl Infect Dis; 2013 Jun; 15(3):314-8. PubMed ID: 23551634
    [Abstract] [Full Text] [Related]

  • 4. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
    Oshima K, Takahashi T, Mori T, Matsuyama T, Usuki K, Asano-Mori Y, Nakahara F, Okamoto S, Kurokawa M, Kanda Y.
    Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
    [Abstract] [Full Text] [Related]

  • 5. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [Abstract] [Full Text] [Related]

  • 6. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y, Mineishi S, Saito T, Saito A, Yamada S, Ohnishi M, Chizuka A, Niiya H, Suenaga K, Nakai K, Takeuchi T, Makimoto A, Tanosaki R, Kami M, Tanaka Y, Fujita S, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y.
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [Abstract] [Full Text] [Related]

  • 7. [Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
    Teranishi H, Sakiyama M, Nagatoshi Y, Nomura Y, Inagaki J, Yanai F, Okamura J.
    Rinsho Ketsueki; 2011 May; 52(5):287-92. PubMed ID: 21646775
    [Abstract] [Full Text] [Related]

  • 8. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.
    Suzuki J, Ashizawa M, Okuda S, Wada H, Sakamoto K, Terasako K, Sato M, Kimura SI, Kikuchi M, Nakasone H, Kako S, Yamazaki R, Oshima K, Nishida J, Kanda Y.
    Transpl Infect Dis; 2012 Aug; 14(4):E7-12. PubMed ID: 22340704
    [Abstract] [Full Text] [Related]

  • 9. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
    Vermont CL, Jol-van der Zijde EC, Hissink Muller P, Ball LM, Bredius RG, Vossen AC, Lankester AC.
    Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
    [Abstract] [Full Text] [Related]

  • 10. [Acute abdomina pain as a presenting symptom of varicella-zoster virus infection in an allogeneic bone marrow transplant].
    Hamanishi T, Nishikawa H, Kobayashi M, Nakao T, Ohagi S, Sasaki H, Matsumoto G, Sanke T, Nanjo K.
    Rinsho Ketsueki; 1998 Jan; 39(1):53-8. PubMed ID: 9492554
    [Abstract] [Full Text] [Related]

  • 11. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S.
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [Abstract] [Full Text] [Related]

  • 12. [Varicella-zoster virus infection after hematopoietic stem cell transplantation].
    Akiyama H, Inoue T, Okoshi Y, Mori S, Ohashi K, Maeda Y, Sasaki T, Okuyama Y, Hiruma K, Sakamaki H.
    Rinsho Ketsueki; 2000 Jan; 41(1):20-4. PubMed ID: 10695394
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [Abstract] [Full Text] [Related]

  • 14. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
    Berman JN, Wang M, Berry W, Neuberg DS, Guinan EC.
    Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
    [Abstract] [Full Text] [Related]

  • 15. [Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
    Aoyama Y, Yamamura R, Shima E, Nakamae H, Makita K, Hasegawa T, Sakamoto C, Terada Y, Kho G, Ohta K, Yamane T, Takubo T, Hino M.
    Rinsho Ketsueki; 2003 Jul; 44(7):451-5. PubMed ID: 12931563
    [Abstract] [Full Text] [Related]

  • 16. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
    Umezawa Y, Kakihana K, Oshikawa G, Kobayashi T, Doki N, Sakamaki H, Ohashi K.
    Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [Abstract] [Full Text] [Related]

  • 19. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I, Brkić S, Bogdanović M.
    Med Pregl; 1999 Jan; 52(3-5):125-8. PubMed ID: 10518396
    [Abstract] [Full Text] [Related]

  • 20. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.
    Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T.
    Transpl Infect Dis; 2019 Aug; 21(4):e13121. PubMed ID: 31127967
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.